The Senate Health, Education, Labor & Pensions Committee still plans to propose legislation this year to advance the interoperability of electronic health records, one of many reasons the administration should wait to finalize Stage 3 meaningful use requirements under the Medicare and Medicaid EHR Incentive Programs, Committee Chairman Lamar Alexander (R-TN) said today at a hearing on “Achieving the Promise of Health Information Technology.” The legislation would be a companion to the 21st Century Cures legislation passed earlier this year by the House. Alexander also urged the administration to immediately adopt proposed changes to the Stage 2 requirements. “The whole purpose of this program is to benefit patients, so that they and their health care providers have quicker and better access to their health histories and their doctors and hospitals and pharmacists can provide them with better care,” Alexander told administration witnesses at the hearing. “There is no reason not to take time to do it right, and there are plenty of reasons to do [so].” On Tuesday, Sens. Bill Cassidy (R-LA) and Sheldon Whitehouse (D-RI) also plan to introduce a bill to address EHR certification issues, Cassidy said.

Headline
The Workgroup for Electronic Data Interchange has launched its fall 2026 survey to assess industry readiness for the Centers for Medicare & Medicaid…
Headline
The Federal Trade Commission announced Sept. 9 that it rescinded its 2021 policy statement that extended applicability of its health breach notification rule…
Headline
Clint Pridgen, vice president of business development and hospital strategy at Laerdal Medical, explores the future of healthcare simulation, including data-…
Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…
Headline
The AHA has released a fact sheet explaining how artificial intelligence tools help alleviate administrative burden for providers, particularly in areas such…
Headline
The Food and Drug Administration is seeking public feedback on a discussion paper released today on potential regulatory approaches for generative artificial…